Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-a... read more Featured Products: More products

Download Mobile App





Co-Diagnostics Introduces Co-Dx PCR Platform and Co-Primers Technology

By LabMedica International staff writers
Posted on 11 Nov 2024

Co-Diagnostics (Salt Lake City, UT, USA), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, is hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf. More...

MEDICA has become the world's largest medical B2B trade fair, attracting 83,000 visitors and over 5,300 exhibitors from almost 70 countries. The company aims to use the opportunity to generate increased interest in its suite of PCR in vitro diagnostic and research products for infectious diseases and to introduce and promote its Co-Primers technology and applications to a wide audience of international attendees.

Co-Primers by Co-Diagnostics is a new class of primer technology that uses a novel architecture to help combat some common issues that can plague multiplex PCR. The unique Co-Primers design reduces primer dimer propagation. Co-Primers technology includes the use of cooperative primers sometimes in combination with other types of primers or probe designs, and is the first PCR technology of its kind to help prevent primer dimer propagation during nucleic acid amplification. In multiplexed reactions where large numbers of primers increase the probability of primer dimer formation, enhanced specificity is particularly important. In a traditional primer process, a pair of primers hybridizes with the sample DNA or RNA sequence and defines the region that will be amplified. In a Co-Primers process, the PCR primer is divided into two segments separated by a PEG (polyethylene glycol) linker. Both the capture sequence and the priming sequence must cooperate to bind to the DNA or RNA target to amplify the intended region. Primer dimers are not propagated because they cannot hybridize to the capture region.

The company's presentation on its upcoming Co-Dx PCR platform is titled "Advancing POC/OTC Diagnostics: Innovations in Test Development for the Co-Dx PCR Platform". The Co-Dx PCR testing platform aims to provide accessible, affordable PCR testing for all, transforming healthcare delivery and creating a positive impact on a global scale by democratizing access to molecular diagnostics. The instrument with dimensions of 6 ½” x 4 1/2” x 6” and weighing two pounds operates via a smartphone app with simple-to-follow instructions that include videos to walk users through every step, some sample swab collection to the straightforward instrument operation. Results are processed in the cloud and delivered back to the user’s smartphone or tablet in about 30 minutes using software designed from the ground up for this specific use. The PCR tests themselves (contained in the simple but unique, innovative test collection cups) are powered by Co-Primers PCR technology.

Related Links:
Co-Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Urinalysis Solution
UN-9000
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.